Biotech Startups

ScienceMachine provides automated quality control for clinical and scientific study documentation, checking reports against protocols and source data to identify missing files and data discrepancies. The platform reconciles study records, calculations, and findings across multiple document formats and integrates with laboratory information systems.

2 investors

SciNeuro develops targeted therapeutics for neurodegenerative and age-related brain diseases by integrating patient genetics, health history, and advanced diagnostic tools. The company collaborates with scientific institutions to create disease-modifying therapies addressing aging populations' neurological challenges.

2 investors

Scoop converts scientific and manufacturing data into dynamic regulatory documents for drug submissions, using AI to continuously reconcile updates and maintain consistency across filings for pharmaceutical companies and regulatory teams.

2 investors

Uh-Oh Labs develops diagnostic tests via its Loop-de-Loop platform, aiming to deliver lab-grade results with lower cost and faster turnaround. It targets underserved point-of-care facilities and at-home, school, and office testing in the public health and diagnostics space.

2 investors

SCYNEXIS is a biopharmaceutical company focused on developing drug therapies for severe rare diseases, including anti-infective and antifungal treatments. The company serves patients in areas of unmet medical need within the pharmaceutical industry.

2 investors

Sea6 Energy develops seaweed-derived biotechnology products and biomaterials for agriculture, animal health, food ingredients, and bioplastics, leveraging ocean farming and bioprocessing technologies. The company operates research facilities, manufacturing units, and processing operations across India and Indonesia.

2 investors

Sealrock is a drug development company whose team has worked on the discovery, development, and commercialization of FDA-approved drugs. It focuses on pharmaceutical research and translational medicine.

2 investors

Seaqure Labs develops mycelium-based protein for animal feed, designed as a sustainable alternative to soy and conventional proteins. The product reduces carbon emissions, water use, and land use significantly while utilizing industrial byproducts in a circular production process.

2 investors

Seascape Clinical provides clinical operations software designed specifically for small and mid-sized biopharma companies, offering streamlined contracting, business case creation, and requirements gathering. The platform prioritizes ease of deployment and integration for resource-constrained biotech teams.

2 investors

This appears to be a research article or blog post from Seer Medical describing a study on using ECG (electrocardiogram) signals for seizure detection as an alternative to traditional EEG-based methods.

2 investors

AkriVita manufactures 3D-printed microcapillary needles designed to improve precision and reliability in biomedical research, genetic research, biotechnology, and fertility treatments. The company serves biomedical scientists and healthcare professionals conducting research, disease prevention modeling, and therapeutic delivery.

2 investors

Sencure designs integrated biosensor chips for wearable health monitoring and medical devices, offering signal processing and electrophysiology expertise. The company serves device manufacturers building health monitoring and wellness applications.

2 investors

SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease. Its work centers on modulating RNA biology to address the molecular mechanisms driving cellular ageing.

2 investors

Senseonics develops and commercializes Eversense, an implantable continuous glucose monitoring system designed to measure blood sugar levels for up to one year in people with diabetes, offering an alternative to conventional glucose monitors that require more frequent sensor replacement. The company sells its system directly and through distribution partners in the United States and Europe.

2 investors

Sensorygen uses computational biology and AI to screen millions of natural compounds and predict their interactions with sensory receptors, aiming to find natural replacements for harsh or toxic ingredients in everyday products. It serves companies in consumer products, agriculture, and beverages through licensed patents and digital screening platforms.

2 investors

Sensulin is a preclinical biopharmaceutical company developing glucose-responsive insulin therapies for type 1 and type 2 diabetes that aim to reduce hypoglycemia risk and daily injection requirements. The company's technology targets long-term complications of diabetes while potentially eliminating the need for separate basal and mealtime insulin dosing.

2 investors

Sentieon develops optimized bioinformatics algorithms for genomic data processing, particularly for precision medicine applications. The company specializes in variant calling and other secondary analysis tools that process next-generation sequencing data.

2 investors

Seqera is a bioinformatics platform that centralizes scientific data, orchestrates pipelines, and provides governance, auditability, and reproducibility across on-premises and cloud environments (AWS, GCP, Azure). Built by the team behind the Nextflow workflow engine, it serves bioinformaticians, lab scientists, and R&D teams working on genomics and AI-based drug discovery.

2 investors

Sequential Skin offers an end-to-end in vivo microbiome testing platform for evaluating skincare, scalp care, oral care, and intimate care products.

2 investors

Serapha Bio is a biotechnology company. It has announced a merger agreement with Boundless Bio alongside a $230 million concurrent private placement.

2 investors

Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine. The company aims to create tailored, long-acting treatments across multiple diseases.

2 investors

This page is a news post from Azafaros, a biopharmaceutical company developing disease-modifying therapeutics for lysosomal storage disorders with a focus on neurological symptoms. The domain belongs to Seroba Life Sciences, but the visible content only covers an Azafaros clinical trial announcement rather than describing the site owner itself.

2 investors

Seven Bridges operates a cloud-based bioinformatics platform for analyzing next-generation sequencing and genomic data, serving distributed research groups and clinical testing teams. The platform provides a library of bioinformatics tools and workflows, elastic cloud/hybrid compute, reproducibility tracking, and graph-based genome analysis for population-scale genomics.

2 investors

SFG Sciences is a drug discovery and development company focused on creating breakthrough therapeutics across various diseases. The company pursues scientific innovations to develop new drugs that improve patients' lives.

2 investors